ARCHIVES

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Texas (Galveston) Scores Nine Points Ahead Of RPMI In Organ Systems Competitio; NCAB To Decide Award

May 4, 1984

In Brief: Search Committee Could Finish Job Weeks, Perry Says Nominations Are Being Solicited

January 11, 1980

Avon Awards $30M To 13 Organizations

September 27, 2002

Expanding Umbilical Cord Stem Cells Found Safe As Standard Transplant

December 26, 2008

NCI Selects 15 Awardees to Operate the Cancer Information Service.

January 7, 2005

In Brief: McDonough Leaves Komen Foundation; Henderson To Head Salk Institute; Alabama Recruits Two

December 4, 1992